{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T19:50:50Z","timestamp":1781034650531,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T00:00:00Z","timestamp":1462924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005006","name":"Asan Institute for Life Sciences, Asan Medical Center","doi-asserted-by":"publisher","award":["2015-090"],"award-info":[{"award-number":["2015-090"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00277-016-2689-8","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T23:25:50Z","timestamp":1462922750000},"page":"1249-1258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma, not otherwise specified treated with chemoimmunotherapy"],"prefix":"10.1007","volume":"95","author":[{"given":"Hee Sang","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dok Hyun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheolwon","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooryung","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,11]]},"reference":[{"key":"2689_CR1","doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma (1993) The international Non-Hodgkin\u2019s lymphoma prognostic factors project. N Engl J Med 329:987\u2013994","DOI":"10.1056\/NEJM199309303291402"},{"key":"2689_CR2","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3109\/10428194.2010.504872","volume":"51","author":"D Hui","year":"2010","unstructured":"Hui D, Proctor B, Donaldson J et al (2010) Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone. Leuk Lymphoma 51:1658\u20131667. doi: 10.3109\/10428194.2010.504872","journal-title":"Leuk Lymphoma"},{"key":"2689_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","volume":"123","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Sehn LH, Rademaker AW et al (2014) An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood 123:837\u2013842. doi: 10.1182\/blood-2013-09-524108","journal-title":"Blood"},{"key":"2689_CR4","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3109\/10428194.2014.982636","volume":"56","author":"CS Lu","year":"2015","unstructured":"Lu CS, Chen JH, Huang TC et al (2015) Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era. Leuk Lymphoma 56:2047\u20132055. doi: 10.3109\/10428194.2014.982636","journal-title":"Leuk Lymphoma"},{"key":"2689_CR5","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1002\/cncr.27381","volume":"118","author":"H Takahashi","year":"2012","unstructured":"Takahashi H, Tomita N, Yokoyama M et al (2012) Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era. Cancer 118:4166\u20134172. doi: 10.1002\/cncr.27381","journal-title":"Cancer"},{"key":"2689_CR6","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s00277-015-2438-4","volume":"94","author":"HS Hwang","year":"2015","unstructured":"Hwang HS, Yoon DH, Suh C, Huh J (2015) Body mass index as a prognostic factor in Asian patients treated with chemoimmunotherapy for diffuse large B cell lymphoma, not otherwise specified. Ann Hematol 94:1655\u20131665. doi: 10.1007\/s00277-015-2438-4","journal-title":"Ann Hematol"},{"key":"2689_CR7","first-page":"233","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"H Stein","year":"2008","unstructured":"Stein H, Chan JKC, Warnke RA et al (2008) Diffuse large B-cell lymphoma, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 233\u2013237"},{"key":"2689_CR8","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"Lister TA, Crowther D, Sutcliffe SB et al (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting. J Clin Oncol 7:1630\u20131636","journal-title":"J Clin Oncol"},{"key":"2689_CR9","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","volume":"16","author":"JO Armitage","year":"1998","unstructured":"Armitage JO, Weisenburger DD (1998) New approach to classifying non-Hodgkin\u2019s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin\u2019s Lymphoma Classification Project. J Clin Oncol 16:2780\u20132795","journal-title":"J Clin Oncol"},{"key":"2689_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275\u2013282. doi: 10.1182\/blood-2003-05-1545","journal-title":"Blood"},{"key":"2689_CR11","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B et al (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI sponsored international working group. J Clin Oncol 17:1244","journal-title":"J Clin Oncol"},{"key":"2689_CR12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/biomet\/67.2.413","volume":"67","author":"AC Atkinson","year":"1980","unstructured":"Atkinson AC (1980) A note on the generalized information criterion for choice of a model. Biometrika 67:413\u2013418","journal-title":"Biometrika"},{"key":"2689_CR13","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: exteding the Cox model","author":"TM Therneau","year":"2000","unstructured":"Therneau TM, Grambsch PM (2000) Modeling survival data: exteding the Cox model. Springer, New York"},{"key":"2689_CR14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB (1996) Multivariate prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361\u2013387","journal-title":"Stat Med"},{"key":"2689_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","volume":"61","author":"PJ Heagerty","year":"2005","unstructured":"Heagerty PJ, Zheng Y (2005) Survival model predictive accuracy and ROC curves. Biometrics 61:92\u2013105. doi: 10.1111\/j.0006-341X.2005.030814.x","journal-title":"Biometrics"},{"key":"2689_CR16","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/bimj.200610301","volume":"48","author":"TA Gerds","year":"2006","unstructured":"Gerds TA, Schumacher M (2006) Consistent estimation of the expected Brier score in general survival models with right-censored event times. Biometrical J Biometrische Zeitschrift 48:1029\u20131040","journal-title":"Biometrical J Biometrische Zeitschrift"},{"key":"2689_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v050.i11","volume":"50","author":"UB Mogensen","year":"2012","unstructured":"Mogensen UB, Ishwaran H, Gerds TA (2012) Evaluating random forests for survival analysis using prediction error curves. J Stat Softw 50:1\u201323","journal-title":"J Stat Softw"},{"key":"2689_CR18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","volume":"54","author":"EW Steyerberg","year":"2001","unstructured":"Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD (2001) Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54:774\u2013781","journal-title":"J Clin Epidemiol"},{"key":"2689_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/hon.2090","volume":"32","author":"T Menter","year":"2014","unstructured":"Menter T, Ernst M, Drachneris J et al (2014) Phenotype profiling of primary testicular diffuse large B-cell lymphomas. Hematol Oncol 32:72\u201381. doi: 10.1002\/hon.2090","journal-title":"Hematol Oncol"},{"key":"2689_CR20","volume-title":"WHO classification of tumors of soft tissue and bone","author":"CDM Fletcher","year":"2013","unstructured":"Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (2013) WHO classification of tumors of soft tissue and bone, 4th edn. IARC, Lyon, France","edition":"4"},{"key":"2689_CR21","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/modpathol.2009.87","volume":"22","author":"A Mozos","year":"2009","unstructured":"Mozos A, Ye H, Chuang WY et al (2009) Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis. Mod Pathol 22:1210\u20131217. doi: 10.1038\/modpathol.2009.87","journal-title":"Mod Pathol"},{"key":"2689_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1756-8722-5-49","volume":"5","author":"YR Kim","year":"2012","unstructured":"Kim YR, Kim JS, Min YH et al (2012) Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the consortium for improving survival of Lymphoma (CISL). J Hematol Oncol 5:49. doi: 10.1186\/1756-8722-5-49","journal-title":"J Hematol Oncol"},{"key":"2689_CR23","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2139","author":"WJ Lee","year":"2015","unstructured":"Lee WJ, Won KH, Won CH et al (2015) Secondary cutaneous diffuse large B-cell lymphoma has a higher international prognostic index score and worse prognosis than diffuse large B-cell lymphoma. Leg Type Acta Derm Venereol. doi: 10.2340\/00015555-2139","journal-title":"Leg Type Acta Derm Venereol"},{"key":"2689_CR24","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3324\/haematol.2011.041277","volume":"96","author":"D Villa","year":"2011","unstructured":"Villa D, Connors JM, Sehn LH, Gascoyne RD, Savage KJ (2011) Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse. Haematologica 96:1002\u20131007. doi: 10.3324\/haematol.2011.041277","journal-title":"Haematologica"},{"key":"2689_CR25","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1182\/blood-2010-06-288480","volume":"117","author":"SJ Kim","year":"2011","unstructured":"Kim SJ, Kang HJ, Kim JS et al (2011) Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. Blood 117:1958\u20131965. doi: 10.1182\/blood-2010-06-288480","journal-title":"Blood"},{"key":"2689_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3346\/jkms.2014.29.1.53","volume":"29","author":"HS Hwang","year":"2014","unstructured":"Hwang HS, Yoon DH, Suh C, Park CS, Huh J (2014) Intestinal diffuse large B-cell lymphoma: an evaluation of different staging systems. J Korean Med Sci 29:53\u201360. doi: 10.3346\/jkms.2014.29.1.53","journal-title":"J Korean Med Sci"},{"key":"2689_CR27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/heartjnl-2011-301246","volume":"98","author":"KG Moons","year":"2012","unstructured":"Moons KG, Kengne AP, Woodward M et al (2012) Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart 98:683\u2013690. doi: 10.1136\/heartjnl-2011-301246","journal-title":"Heart"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2689-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-016-2689-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2689-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T10:10:02Z","timestamp":1567851002000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-016-2689-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,11]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["2689"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2689-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,11]]}}}